ribavirin has been researched along with adenosine in 38 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 7 (18.42) | 18.7374 |
1990's | 10 (26.32) | 18.2507 |
2000's | 6 (15.79) | 29.6817 |
2010's | 11 (28.95) | 24.3611 |
2020's | 4 (10.53) | 2.80 |
Authors | Studies |
---|---|
Drabikowska, AK; Dudycz, L; Shugar, D | 1 |
Bergogne, MC; De Clercq, E; De Rudder, J; Gosselin, G; Imbach, JL | 1 |
Benz, RD; Contrera, JF; Kruhlak, NL; Matthews, EJ; Weaver, JL | 1 |
Bellows, DS; Clarke, ID; Diamandis, P; Dirks, PB; Graham, J; Jamieson, LG; Ling, EK; Sacher, AG; Tyers, M; Ward, RJ; Wildenhain, J | 1 |
Gäredal, M; Jacobsson, M; Karlén, A; Schultz, J | 1 |
Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
Choi, SS; Contrera, JF; Hastings, KL; Kruhlak, NL; Sancilio, LF; Weaver, JL; Willard, JM | 1 |
Chiba, K; Fukuchi, Y; Furihata, T; Hashizume, M; Iikura, M; Miyajima, A; Nagai, M | 1 |
Fisk, L; Greene, N; Naven, RT; Note, RR; Patel, ML; Pelletier, DJ | 1 |
Ekins, S; Williams, AJ; Xu, JJ | 1 |
Hong, J; Johnson, ZL; Kwon, DY; Lee, JH; Lee, K; Lee, M; Lee, SY | 1 |
Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
Murphy, MF | 1 |
Ivanovics, GA; Robins, RK; Rousseau, RJ; Srivastava, PC | 1 |
Baba, M; Honzumi, K; Ito, M; Matsuda, A; Mori, S; Nakamura, K; Numazaki, Y; Obara, T; Oshitani, H; Shigeta, S | 1 |
Plunkett, W; Saunders, PP | 1 |
De Clercq, E; Marquez, VE; Murase, J | 1 |
De Clercq, E; Kitaoka, S; Konno, T | 1 |
Gupta, RS; Mehta, KD | 1 |
Betts, CR; Cooney, DA; Gebeyehu, G; Jayaram, HN; Johns, DG; Kelley, JA; Marquez, VE | 1 |
Balzarini, J; Bohman, C; De Clercq, E; Fridland, A; Herdewijn, P; Horská, K; Karlsson, A; Van Aerschot, A; Votruba, I; Wang, L | 1 |
Itoh, H; Kosugi, Y; Matsuda, A; Obara, T; Saito, Y; Shigeta, S; Shuto, S; Toriya, M; Yaginuma, S | 1 |
De Clercq, E; Hosoya, M; Ishii, T; Shigeta, S; Suzuki, H | 1 |
De Clercq, E; González, M; Jashés, M; López-Lastra, M; Sandino, A | 1 |
Glue, P; Jarvis, SM; Thorn, JA | 1 |
Iakovleva, EP; Mosunova, TV | 1 |
Averett, DR; Briese, T; Jordan, I; Lipkin, WI | 1 |
Aldrich, C; Bennett, E; Cappellacci, L; Chen, L; Di Stefano, M; Felczak, K; Franchetti, P; Grifantini, M; Magni, G; Mazzola, F; Pankiewicz, KW; Petrelli, R; Sham, YY; Wilson, D; Yu, JS | 1 |
Bjelobaba, I; Dacic, S; Lavrnja, I; Mostarica-Stojkovic, M; Nedeljkovic, N; Pekovic, S; Rakic, L; Stojiljkovic, M; Stojkov, D; Stosic-Grujicic, S | 1 |
Cheung, PP; Choy, KT; Fun Sia, S; Guan, Y; Kellam, P; Malik Peiris, JS; Poon, LL; Watson, SJ; Wong, DD; Yen, HL | 1 |
Luo, R; Nong, J; Qing, J; Shao, Y; Sun, Y; Tang, R; Wang, Y; Wu, M; Yin, Z; Yu, X | 1 |
Alam, R; Barbarovich, AT; Barskaya, A; Caravan, W; Ismail, M; Parkin, DW; Stockman, BJ | 1 |
Kaur, R; Mudgal, R; Narwal, M; Tomar, S | 1 |
Ben-Khalifa, Y; Bourhy, H; Jochmans, D; Larrous, F; Neyts, J; Rogée, S | 1 |
Kesić, S; Pešić, V; Petković, B | 1 |
Carvalho Junior, RN; J C Neto, AM; Martins, AY; Reis, AF; S Costa, JF; Silva Arouche, TD | 1 |
Celik, I; Duzgun, Z; Erol, M | 1 |
Assis, LC; da Cunha, EFF; de Almeida La Porta, F; de Castro Ramalho, T; de Castro, AA; de Jesus, JPA; Kuca, K; Nepovimova, E | 1 |
3 review(s) available for ribavirin and adenosine
Article | Year |
---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
Metabolism and action of purine nucleoside analogs.
Topics: 2-Chloroadenosine; Adenosine; Cladribine; Deoxyadenosines; Guanine; Guanosine; Humans; Purine Nucleosides; Ribavirin; Vidarabine | 1991 |
Critical View on the Usage of Ribavirin in Already Existing Psychostimulant-Use Disorder.
Topics: Adenosine; Amphetamine; Animals; Brain; Brain Chemistry; Central Nervous System Stimulants; Humans; Receptors, Dopamine D1; Ribavirin; Substance-Related Disorders | 2020 |
35 other study(ies) available for ribavirin and adenosine
Article | Year |
---|---|
Studies on the mechanism of antiviral action of 1-(beta-D-ribofuranosyl)-1,2,4-triazole-3-carboxamide (ribavirin).
Topics: Animals; Hydrolysis; IMP Dehydrogenase; In Vitro Techniques; Liver; Phosphorylation; Phosphotransferases; Rats; Ribavirin; Ribonucleosides; Spleen; Viruses | 1979 |
Systematic synthesis and biological evaluation of alpha- and beta-D-lyxofuranosyl nucleosides of the five naturally occurring nucleic acid bases.
Topics: Animals; Antiviral Agents; Herpes Simplex; Mice; Nucleosides | 1987 |
Assessment of the health effects of chemicals in humans: II. Construction of an adverse effects database for QSAR modeling.
Topics: Adverse Drug Reaction Reporting Systems; Artificial Intelligence; Computers; Databases, Factual; Drug Prescriptions; Drug-Related Side Effects and Adverse Reactions; Endpoint Determination; Models, Molecular; Quantitative Structure-Activity Relationship; Software; United States; United States Food and Drug Administration | 2004 |
Chemical genetics reveals a complex functional ground state of neural stem cells.
Topics: Animals; Cell Survival; Cells, Cultured; Mice; Molecular Structure; Neoplasms; Neurons; Pharmaceutical Preparations; Sensitivity and Specificity; Stem Cells | 2007 |
Identification of Plasmodium falciparum spermidine synthase active site binders through structure-based virtual screening.
Topics: Animals; Binding Sites; Databases, Factual; Heterocyclic Compounds, 1-Ring; Heterocyclic Compounds, 2-Ring; Hydrogen Bonding; Magnetic Resonance Spectroscopy; Models, Molecular; Plasmodium falciparum; Protein Binding; Quantitative Structure-Activity Relationship; Spermidine Synthase; Structure-Activity Relationship | 2008 |
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Development of a phospholipidosis database and predictive quantitative structure-activity relationship (QSAR) models.
Topics: | 2008 |
Striking species difference in the contribution of concentrative nucleoside transporter 2 to nucleoside uptake between mouse and rat hepatocytes.
Topics: Adenosine; Animals; Biological Transport; Hepatocytes; Male; Membrane Transport Proteins; Mice; Mice, Inbred C57BL; Nucleosides; Rats; Rats, Sprague-Dawley; Ribavirin; Sodium | 2010 |
Developing structure-activity relationships for the prediction of hepatotoxicity.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Humans; Structure-Activity Relationship; Tetracyclines; Thiophenes | 2010 |
A predictive ligand-based Bayesian model for human drug-induced liver injury.
Topics: Bayes Theorem; Chemical and Drug Induced Liver Injury; Humans; Ligands | 2010 |
Structural basis of nucleoside and nucleoside drug selectivity by concentrative nucleoside transporters.
Topics: Animals; Bacterial Proteins; Binding Sites; Biological Transport; Crystallography, X-Ray; Deoxycytidine; Female; Gemcitabine; Gene Expression; Humans; Kinetics; Membrane Transport Proteins; Molecular Docking Simulation; Nucleoside Transport Proteins; Oocytes; Protein Binding; Quantitative Structure-Activity Relationship; Recombinant Proteins; Ribavirin; Substrate Specificity; Thermodynamics; Uridine; Vibrio cholerae; Xenopus laevis | 2014 |
In vitro inhibition of subacute sclerosing panencephalitis virus by the antiviral agent ribavirin.
Topics: Adenosine; Antiviral Agents; Epitopes; Guanosine; Measles virus; Microbial Sensitivity Tests; Ribavirin; Ribonucleosides; SSPE Virus; Viral Plaque Assay | 1978 |
[Nucleosides of 4-substituted imidazoles].
Topics: Adenosine; Deamination; Imidazoles; Ribavirin; Ribonucleosides | 1975 |
Antiviral activities of ribavirin, 5-ethynyl-1-beta-D-ribofuranosylimidazole-4-carboxamide, and 6'-(R)-6'-C-methylneplanocin A against several ortho- and paramyxoviruses.
Topics: Adenosine; Animals; Antiviral Agents; Cell Survival; Cells, Cultured; HeLa Cells; Humans; Orthomyxoviridae; Paramyxoviridae; Ribavirin; Ribonucleosides; Vero Cells | 1992 |
Broad-spectrum antiviral and cytocidal activity of cyclopentenylcytosine, a carbocyclic nucleoside targeted at CTP synthetase.
Topics: Adenosine; Amides; Antiviral Agents; Azauridine; Carbon-Nitrogen Ligases; Cell Division; Cytarabine; Cytidine; Deoxycytidine; Drug Synergism; Fluorouracil; HeLa Cells; Humans; Ligases; Nucleosides; Pyrazoles; Ribavirin; Ribonucleosides; Ribose; Thymidine; Tumor Cells, Cultured; Uracil; Virus Replication; Viruses | 1991 |
Comparative efficacy of broad-spectrum antiviral agents as inhibitors of rotavirus replication in vitro.
Topics: Adenine; Adenosine; Amides; Antiviral Agents; Cell Line; Cytidine; Dose-Response Relationship, Drug; Pyrazoles; Ribavirin; Ribonucleosides; Ribose; Rotavirus; Tubercidin; Vidarabine; Virus Replication | 1986 |
Chinese hamster ovary cell mutants specifically affected in the phosphorylation of C-purine nucleosides.
Topics: Adenosine; Animals; Antibiotics, Antineoplastic; Cell Line; Cricetinae; Cricetulus; Drug Resistance; Female; Formycins; Ovary; Phosphorylation; Purine Nucleosides; Ribavirin; Time Factors; Tubercidin | 1985 |
The conversion of 2-beta-D-ribofuranosylthiazole-4-carboxamide to an analogue of NAD with potent IMP dehydrogenase-inhibitory properties.
Topics: Adenosine; Animals; Antineoplastic Agents; IMP Dehydrogenase; Ketone Oxidoreductases; Kinetics; Leukemia P388; Male; Mice; NAD; Ribavirin; Ribonucleosides | 1982 |
Eicar (5-ethynyl-1-beta-D-ribofuranosylimidazole-4-carboxamide). A novel potent inhibitor of inosinate dehydrogenase activity and guanylate biosynthesis.
Topics: Adenosine; Animals; Antineoplastic Agents; Cell Division; Deoxyguanine Nucleotides; Guanine; Guanosine; Guanosine Triphosphate; Humans; IMP Dehydrogenase; Leukemia L1210; Lymphocytes; Mice; Mycophenolic Acid; Purine Nucleotides; Ribavirin; Ribonucleosides; Ribonucleotides; Tumor Cells, Cultured | 1993 |
New neplanocin analogues. IV. 2-Fluoroneplanocin A: an adenosine deaminase-resistant equivalent of neplanocin A.
Topics: Adenosine; Adenosine Deaminase; Animals; Antibiotics, Antineoplastic; Antiviral Agents; Drug Resistance; Fibrosarcoma; Mice; Ribavirin; RNA Viruses | 1994 |
Comparative inhibitory effects of various nucleoside and nonnucleoside analogues on replication of influenza virus types A and B in vitro and in ovo.
Topics: Adenosine; Animals; Antiviral Agents; Benzamidines; Cells, Cultured; Chick Embryo; Dextran Sulfate; Dose-Response Relationship, Drug; Esters; Gabexate; Guanidines; Guanosine; Influenza A virus; Influenza B virus; Nucleosides; Protease Inhibitors; Ribavirin; Virus Replication | 1993 |
Inhibitors of infectious pancreatic necrosis virus (IPNV) replication.
Topics: Adenosine; Adenosylhomocysteinase; Amides; Animals; Antiviral Agents; Cell Line; DNA; Foscarnet; Hydrolases; IMP Dehydrogenase; Infectious pancreatic necrosis virus; Orotidine-5'-Phosphate Decarboxylase; Pyrazoles; Ribavirin; Ribonucleosides; Ribose; Salmon; Viral Plaque Assay; Virus Replication | 1996 |
Ribavirin uptake by human erythrocytes and the involvement of nitrobenzylthioinosine-sensitive (es)-nucleoside transporters.
Topics: Adenosine; Animals; Antiviral Agents; Carrier Proteins; Equilibrative-Nucleoside Transporter 2; Erythrocyte Membrane; Erythrocytes; Horses; Humans; In Vitro Techniques; Membrane Proteins; Ribavirin; Thioinosine; Uridine | 1998 |
[Search for microorganisms among collectable bacterial strains capable of transforming nucleosides into virazole].
Topics: Adenosine; Antiviral Agents; Bacteria; Chromatography, Thin Layer; Culture Media; Guanosine; Hydrolysis; Inosine; Purine-Nucleoside Phosphorylase; Ribavirin; Ribose; Solutions; Spectrophotometry, Ultraviolet | 1998 |
Inhibition of Borna disease virus replication by ribavirin.
Topics: Adenosine; Animals; Antiviral Agents; Borna disease virus; Cell Line; Guanosine; Guanosine Triphosphate; Humans; Neuroglia; Oligodendroglia; Rats; Ribavirin; Virus Replication | 1999 |
Selective inhibition of nicotinamide adenine dinucleotide kinases by dinucleoside disulfide mimics of nicotinamide adenine dinucleotide analogues.
Topics: Adenosine; Binding Sites; Disulfides; Humans; Models, Molecular; Molecular Conformation; Mycobacterium tuberculosis; NAD; Phosphotransferases (Alcohol Group Acceptor); Ribavirin | 2009 |
Ribavirin administration alters ectonucleotidase activities in experimental autoimmune encephalomyelitis.
Topics: 5'-Nucleotidase; Adenine Nucleotides; Adenosine; Animals; Anti-Inflammatory Agents; Cell Membrane; Encephalomyelitis, Autoimmune, Experimental; Female; Hydrolysis; Neuroprotective Agents; Rats; Ribavirin; Spinal Cord | 2009 |
Generation and characterization of influenza A viruses with altered polymerase fidelity.
Topics: Adenosine; Animals; Antiviral Agents; Drug Resistance, Viral; Female; Genetic Variation; Guanosine; Influenza A Virus, H3N2 Subtype; Influenza A Virus, H5N1 Subtype; Lung; Mice; Mice, Inbred BALB C; Mutation; Orthomyxoviridae Infections; Reassortant Viruses; Ribavirin; RNA-Dependent RNA Polymerase; Survival Analysis; Viral Proteins; Viral Tropism | 2014 |
Resistance analysis and characterization of NITD008 as an adenosine analog inhibitor against hepatitis C virus.
Topics: Adenosine; Antiviral Agents; Cell Line; Drug Resistance, Viral; Hepacivirus; Hepatitis C; Hepatitis C, Chronic; Humans; Interferon-alpha; Mutation; Oligopeptides; Protease Inhibitors; Replicon; Ribavirin; RNA, Viral; Sofosbuvir; Viral Nonstructural Proteins; Virus Replication | 2016 |
Druggability of the guanosine/adenosine/cytidine nucleoside hydrolase from Trichomonas vaginalis.
Topics: Adenosine; Enzyme Inhibitors; Inhibitory Concentration 50; N-Glycosyl Hydrolases; Protozoan Proteins; Quercetin; Ribavirin; Structure-Activity Relationship; Trichomonas vaginalis | 2018 |
Development of an ELISA assay for screening inhibitors against divalent metal ion dependent alphavirus capping enzyme.
Topics: Adenosine; Antiviral Agents; Aurintricarboxylic Acid; Cations, Divalent; Chikungunya virus; Coenzymes; Drug Evaluation, Preclinical; Enzyme Inhibitors; Enzyme-Linked Immunosorbent Assay; Inhibitory Concentration 50; Magnesium; Methyltransferases; Ribavirin; Viral Proteins | 2018 |
Pyrimethamine inhibits rabies virus replication in vitro.
Topics: Adenosine; Animals; Antiviral Agents; Drug Synergism; Mice; Mice, Inbred BALB C; Pyrimethamine; Rabies virus; Ribavirin; Small Molecule Libraries; Virus Replication | 2019 |
Interactions Between Remdesivir, Ribavirin, Favipiravir, Galidesivir, Hydroxychloroquine and Chloroquine with Fragment Molecular of the COVID-19 Main Protease with Inhibitor N3 Complex (PDB ID:6LU7) Using Molecular Docking.
Topics: Adenine; Adenosine; Adenosine Monophosphate; Alanine; Amides; Antiviral Agents; Betacoronavirus; Binding Sites; Chloroquine; Coronavirus 3C Proteases; Coronavirus Infections; COVID-19; COVID-19 Drug Treatment; Cysteine Endopeptidases; Drug Interactions; Humans; Hydrogen Bonding; Hydroxychloroquine; Ligands; Molecular Docking Simulation; Nanotechnology; Pandemics; Pneumonia, Viral; Protease Inhibitors; Pyrazines; Pyrrolidines; Ribavirin; SARS-CoV-2; Static Electricity; Viral Nonstructural Proteins | 2020 |
In silico evaluation of potential inhibitory activity of remdesivir, favipiravir, ribavirin and galidesivir active forms on SARS-CoV-2 RNA polymerase.
Topics: Adenine; Adenosine; Adenosine Monophosphate; Alanine; Amides; Antiviral Agents; COVID-19 Drug Treatment; Drug Repositioning; Humans; Molecular Docking Simulation; Molecular Dynamics Simulation; Pyrazines; Pyrrolidines; Ribavirin; RNA, Viral; SARS-CoV-2 | 2022 |
Effect of drug metabolism in the treatment of SARS-CoV-2 from an entirely computational perspective.
Topics: Adenine; Adenosine; Adenosine Monophosphate; Alanine; Amides; Antiviral Agents; Chloroquine; COVID-19; COVID-19 Drug Treatment; Drug Design; Drug Discovery; Humans; Metabolic Networks and Pathways; Molecular Docking Simulation; Nitro Compounds; Pyrazines; Pyrrolidines; Ribavirin; SARS-CoV-2; Thiazoles | 2021 |